The WHO classification of tumors of the nervous system

Journal of Neuropathology and Experimental Neurology

Volumn 61, Issue 3, 2002, Pages 215-225

  Kleihues, Paul ^a   Louis, David N ^a   Scheithauer, Bernd W ^a   Rorke, Lucy B ^a   Reifenberger, Guido ^a   Burger, Peter C ^a   Cavenee, Webster K ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER GRADING; CHROMOSOME 19Q; CHROMOSOME 1P; CHROMOSOME 22Q; CLINICAL FEATURE; EPENDYMOMA; GENETIC ANALYSIS; GLIOBLASTOMA; GLIOMA; HEREDITY; HISTOPATHOLOGY; HUMAN; MEDULLOBLASTOMA; MOLECULAR BIOLOGY; MOLECULAR GENETICS; NERVE TUMOR; NERVOUS SYSTEM TUMOR; NEUROEPITHELIOMA; NEUROPATHOLOGY; PRIORITY JOURNAL; RHABDOID TUMOR; RISK FACTOR; TERATOMA; TUMOR CLASSIFICATION; WORLD HEALTH ORGANIZATION;

EID: 0036192918     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/61.3.215     Document Type: Article

References (75)

1. The new WHO classification of brain tumours
2. Epidemiology. Incidence and survival
3. Grading of astrocytomas. A simple and reproducible method
4. Subsets of glioblastoma multiforme defined by molecular genetic analysis
5. Pathways leading to glioblastoma multiforme: A molecular analysis of genetic alterations in 65 astrocytic tumors
6. Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas
7. Phenotype vs genotype in the evolution of astrocytic brain tumors
8. Primary and secondary glioblastoma: From concept to clinical diagnosis
9. Glioma classification: A molecular reappraisal
10. Cellular proliferation in pilocytic and diffuse astrocytomas
11. Current treatment of oligodendrogliomas
12. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas
13. Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas
14. Oligodendrocyte lineage genes (OLIG) as molecular markers for human glial brain tumors
15. Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p
16. Molecular genetic evidence for subtypes of oligoastrocytomas
17. Long survival and therapeutic responses in patients with histologically disparate high-grade gliomas demonstrating chromosome 1p loss
18. Glioblastoma with oligodendroglial features (GBM-OL): Report from Radiation Therapy Oncology Group (RTOG) trial 8302
19. Molecular genetic alterations in glioblastomas with oligodendroglial component
20. Tanycytic ependymoma
21. A case of syringomyelia associated with an intramedullary tumor, with remarks on the relation of the gliosis to tumors of ependymal origin
22. The cytogenetic basis for classifying ependymomas
23. The tanycytic ependymoma of the lateral ventricle: Case report
24. Ganglioglioma with a tanycytic ependymoma as the glial component
25. Duplication of N-MYC at its resident site 2p24 may be a mechanism of activation alternative to amplification in human neuroblastoma cells
26. Third ventricular chordoid glioma: A distinct clinicopathologic entity
27. Chordoid glioma of the third ventricle: Immunohistochemical and molecular genetic characterization of a novel tumor entity
28. Chordoid meningioma: A clinicopathologic study of 42 cases
29. Meningocerebral astrocytoma attached to dura with "desmoplastic" reaction
30. Desmoplastic supratentorial neuroepithelial tumors of infancy with divergent differentiation potential ("desmoplastic infantile gangliogliomas"). Report on 11 cases of a distinctive embryonal tumor with favorable prognosis
31. Mixed mesenchymal and neuroectodermal tumor of the cerebellum
32. Lipomatous medulloblastoma in adults: A new tumor type with possible favorable prognosis
33. Lipomatous medulloblastoma in adults: A distinct clinicopathological entity
34. Medullocytoma (lipidized medulloblastoma): A cerebellar neoplasm of adults with favorable prognosis
35. The cerebellar medulloblastoma and its relationship to primitive neuroectodermal tumors
36. Primitive neuroectodermal tumors of the central nervous system
37. Sporadic medulloblastomas contain PTCH mutations
38. Control of neuronal precursor proliferation in the cerebellum by sonic hedgehog
39. Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum
40. APC mutations in sporadic medulloblastomas
41. Aberrant hypermethylation of the major breakpoint cluster region in 17p11.2 in medulloblastomas but not supratentorial PNETs
42. Outcome for children with supratentorial primitive neuroectodermal tumors treated with surgery, radiation, and chemotherapy
43. Pineal and nonpineal supratentorial primitive neuroectodermal tumors
44. Large-cell medulloblastoma
45. Multiple genomic alterations including N-myc amplification in a primary large cell medulloblastoma
46. Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: Definition of an entity
47. Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors
48. Mutations of the INI1 rhabdoid tumor suppressor gene in medulloblastomas and primitive neuroectodermal tumors of the central nervous system
49. "Malignancy" in meningiomas: A clinicopathologic study of 116 patients, with grading implications
50. Meningioma grading: An analysis of histologic parameters
51. Factors affecting operative and excess long-term mortality in 935 patients with intracranial meningioma
52. Classic, atypical, and anaplastic meningioma: Three histopathological subtypes of clinical relevance
53. Loss of heterozygosity for loci on chromosome 10 is associated with morphologically malignant meningioma progression
54. Allelic losses on chromosomes 14. 10, and 1 in atypical and malignant meningiomas: A genetic model of meningioma progression
55. Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: Toward a genetic model of meningioma progression
56. Intraneural perineurioma. A clonal neoplasm associated with abnormalities of chromosome 22
57. Intratemporal facial nerve perineurioma
58. Ultrastructural identification of a benign perineurial cell tumor
59. Perineurioma of the mandible
60. Renal perineurioma in childhood
61. Soft-tissue perineurioma. Evidence for an abnormality of chromosome 22, criteria for diagnosis, and review of the literature
62. Sclerosing perineurioma: A clinicopathologic study of 19 cases of a distinctive soft tissue lesion with a predilection for the fingers and palms of young adults
63. Papillary glioneuronal tumor: A new variant of mixed neuronal-glial neoplasm
64. A distinctive glioneuronal tumor of the adult cerebrum with neuropil-like (including "rosetted") islands: Report of 4 cases
65. Lipoastrocytoma: A rare low-grade astrocytoma variant of pediatric age
66. Lipomatous meningioma: A clinicopathologic study of 18 cases with special reference to the issue of metaplasia
67. Medulloblastoma with extensive nodularity: A variant with favorable prognosis